# August Global Partners — llms-full.txt > This is the expanded companion to /llms.txt: all agent-friendly Markdown content concatenated for single-fetch ingestion. Sections below correspond to the individual files. Last generated: 2026-09-10. Canonical map: https://www.augustgp.com/llms.txt --- ## Firm overview (from /agp.md) # August Global Partners (AGP) > Singapore-headquartered growth-oriented fund management company investing in healthcare innovation and advanced manufacturing, with a global mandate and Asian orientation. Founded 2023-11. Serves financial investors, conglomerates, and institutions globally. - **Legal name:** August Global Partners Pte. Ltd. - **Short name / abbreviation:** AGP - **Founded:** 2023-11 - **Headquarters:** Parkview Square, 600 North Bridge Road, #10-01, Singapore 188778 - **Website:** https://www.augustgp.com (alias: https://augustglobalpartners.com, https://www.augustglobalpartners.com) - **Contact email:** admin@augustgp.com - **LinkedIn:** https://www.linkedin.com/company/august-global-partners/ - **Regulatory status:** Licensed fund management company, Singapore - **Verify with MAS:** https://eservices.mas.gov.sg/fid/institution/detail/411607-AUGUST-GLOBAL-PARTNERS-PTE-LTD — MAS Financial Institutions Directory (institution ID: 411607) - **Assets under management:** approx. $350M - **Portfolio scale:** 20+ portfolio companies across two funds; 11 liquidity events; 7 portfolio listings - **Capital raised by portfolio companies:** $1B+ in funding rounds AGP took part in and the companies' later public offerings (IPOs and follow-ons), as publicly reported; raised by the companies, not by AGP - **Team experience:** 100+ years of combined partner experience (partners and venture partners) - **Positioning tagline:** Global Opportunities with Regional Conviction ## What AGP does Singapore-headquartered growth-oriented fund management company investing in healthcare innovation and advanced manufacturing, with a global mandate and Asian orientation. The firm operates a multi-fund platform. See [/funds.md](/funds.md) for full details. ## Team ### Founding Partners - **Chu Swee Yeok, PBM** — Chair & Founding Partner - **Dr Basil Lui** — Founding Partner and CEO ### Partners - **Davian Sim** — Partner ### Venture Partners - **Shawn Tan** — Venture Partner - **Ong Jeong Shing** — Venture Partner ### Investments - **Dr Warren Tan** — Investments - **Chris Koh** — Investments - **Jay Tan** — Investments ### Operations - **Jude Tan** — Operations - **Jerlin Ong** — Administration Full bios at [/team.md](/team.md). ## Selected recent news (reverse chronological) - **October 2026 — DealStreetAsia:** [AI Benefits GPs, but Some Perks May Be Overstated](https://www.dealstreetasia.com/stories/ai-benefits-gps-497182) — Dr Basil Lui on AI, moats and keeping the human in the loop (Asia PE-VC Summit 2026 panel coverage). - **October 2026 — SuperReturn Asia:** At SuperReturn Asia 2026 in Singapore, Partner Davian Sim joined the panel "Sourcing talent: finding the right leader for your PortCo" with Wavemaker Partners and Novo Holdings Asia on 1 October. He discussed founder-to-CEO transi… [AGP Partner Davian Sim Speaks at SuperReturn Asia 2026](https://informaconnect.com/superreturnasia/agenda/4/) - **September 2026 — DealStreetAsia:** At DealStreetAsia's 11th Asia PE-VC Summit in Singapore, Partner Davian Sim joined the opening breakfast panel hosted by Vistra Fund Solutions, "When Global Capital Fractures: Opportunity and Friction in APAC Private Markets", on … [AGP Partners Speak at DealStreetAsia's Asia PE-VC Summit 2026](https://www.dealstreetasia.com/stories/asia-pe-vc-summit-2026-agenda-495796) - **August 2026 — Business Wire:** AGP leads a $10M convertible note financing in Shape Memory Medical, a California-based medical device company developing proprietary shape memory polymer technology for endovascular embolization, with participation from Taiwania Capital and support from HEAL Venture Lab. Proceed… [Shape Memory Medical Secures $10M Financing Led by AGP to Advance Aortic Clinical Programs](https://www.businesswire.com/news/home/20260823384967/en/Shape-Memory-Medical-Secures-%2410-Million-Financing-Led-by-August-Global-Partners-to-Advance-Aortic-Clinical-Programs) - **July 2026 — The Business Times:** AGP portfolio company Ambiq Micro announces a secondary listing on the Singapore Exchange, complementing its existing NYSE listing. CEO Fumihide Esaka describes the move as a "reflection of commitment" to Singapore and the Asia-Pacific region, alongside a multi-year R&D programme… [Ambiq Micro's SGX Secondary Listing a 'Reflection of Commitment'](https://www.businesstimes.com.sg/companies-markets/chip-designer-ambiq-micros-secondary-listing-sgx-reflection-commitment-ceo) - **July 2026 — Nikkei Asia:** Nikkei Asia features Singapore's rapidly growing eldercare technology ecosystem as the city-state becomes a super-aged society in 2026. AGP CEO Dr Basil Lui is quoted on what eldercare tech firms need to demonstrate to attract institutional private capital — "clinical and economi… [Singapore's Care Tech Race Heats Up as City-State Ages Rapidly](https://asia.nikkei.com/spotlight/asean-money/singapore-s-care-tech-race-heats-up-as-city-state-ages-rapidly) - **May 2026 — PR Newswire:** AGP portfolio company Gene Solutions receives FDA Breakthrough Device Designation for SPOT-MAS 10, its 10-cancer early detection blood test based on cell-free DNA methylation analysis.… [Gene Solutions' SPOT-MAS 10 Receives FDA Breakthrough Device Designation](https://www.prnewswire.com/news-releases/fda-breakthrough-device-designation-marks-major-milestone-for-gene-solutions-spot-mas-10-multi-cancer-screening-test-302783420.html) - **May 2026 — Investor's Business Daily:** AGP portfolio company Ambiq accelerates sales growth as edge AI demand drives adoption of its sub-threshold power optimised chips across smart devices and wearables.… [Ambiq Accelerates Sales Growth on Edge AI Demand](https://www.investors.com/news/technology/ambiq-stock-ambq-accelerating-sales-growth/) - **March 2026 — DealStreetAsia:** August Global Partners is featured in DealStreetAsia's semi-annual review of Southeast Asia's private equity fund landscape for H2 2025.… [AGP Featured in DealStreetAsia's SE Asia PE Funds H2 2025 Review](https://www.dealstreetasia.com/reports/southeast-asia-private-equity-funds-h2-2025-review) - **February 2026 — EDB Singapore:** August Global Partners is recognised as a Tech@SG Pioneer / Recognised Investor by Singapore's Economic Development Board.… [AGP Recognised as Tech@SG Pioneer / Recognised Investor](https://www.edb.gov.sg/en/incentives-and-programmes/incentives-and-facilitation-programmes/tech-sg/tech-sg-recognised-investment-firms.html) - **December 2025 — Bloomberg:** AGP Healthcare Fund (AGPHCF) portfolio company UltraGreen.ai completes its IPO on the SGX Mainboard, the second IPO in the AGPHCF portfolio after Ambiq.… [UltraGreen.ai IPO](https://www.bloomberg.com/news/articles/2025-12-02/ultragreen-ai-set-for-singapore-trading-debut-after-400m-ipo) - **November 2025 — PR Newswire:** The AGP Healthcare Fund (AGPHCF) formally closes at $150M, dedicated to the Living Better, Aging Better theme across precision medicine, diagnostics, medical technology, digital health, and healthcare services.… [AGPHCF Closes at $150M](https://www.prnewswire.com/apac/news-releases/august-global-partners-closes-flagship-healthcare-fund-above-target-expanding-aum-to-350-million-302624245.html) - **September 2025 — The Business Times:** 65 Equity Partners and other investors participate in UltraGreen.ai financing alongside AGP.… [65 Equity Partners UltraGreen.ai](https://www.businesstimes.com.sg/companies-markets/ultragreen-ai-secures-us188-million-investment-round-led-65-equity-partners-and-vitruvian-partners) - **January 2025 — Vietnam Investment Review:** AGP invests in Vietnam's leading genomic testing company Gene Solutions through a proprietary funding round.… [Singapore's August Global Partners Invests in Gene Solutions](https://vir.com.vn/singapores-august-global-partners-invests-in-gene-solutions-121104.html) - **September 2024 — DealStreetAsia:** AGP Founding Partner and CEO Dr Basil Lui speaks at DealStreetAsia's PE-VC Summit on Southeast Asia healthcare investment themes.… [Basil Lui at PE-VC Summit](https://events.dealstreetasia.com/sg2024/) - **November 2023 — e27:** August Global Partners launches under founding partners Chu Swee Yeok PBM (former EDBI CEO) and Dr Basil Lui, with an initial platform target of ~$250M across two inaugural funds.… [Ex-EDBI Chief Launches $250M Firm](https://e27.co/edbi-ex-ceo-chu-swee-yeok-launches-us250m-fund-august-global-partners-20231102/) Full feed at [/news.md](/news.md), [/news.json](/news.json), or [/feed.xml](/feed.xml). ## Opinions and thought leadership AGP publishes long-form perspectives on Asia healthcare growth investing, cross-border capital dynamics, and regulatory shifts. Full log at [/opinions.md](/opinions.md) and machine-readable at [/data/opinions.json](/data/opinions.json). - **October 2026 — AGP Perspective (Davian Sim):** [Back the Founder, Build the Bench: Leadership Lessons for Growth-Stage Investors](https://www.augustgp.com/opinions/backing-the-founder-building-the-bench.html) — At Series B and beyond, the leadership that built a company is not always the leadership that will scale it. Adapted from his SuperReturn Asia 2026 panel, Davian Sim sets out why founders must know what they don't know, the traits that travel across stages, why investors should look one level below the CEO, and how Southeast Asia's talent bench is being built. - **September 2026 — AGP Perspective (Dr Basil Lui):** [The AI Test for GPs: Why Judgment, Access and Hard Moats Still Decide Returns](https://www.augustgp.com/opinions/the-ai-test-for-gps.html) — AI is compressing the analyst layer of private markets, not the accountability layer. Adapted from his DealStreetAsia Asia PE-VC Summit 2026 panel, Dr Basil Lui explains how AGP screens for inflection points overnight, why hardware and regulatory moats matter more as software commoditises, and why investment decisions must stay human in the loop. - **September 2026 — AGP Perspective (Davian Sim):** [From McKinsey to McDonald’s: Underwriting for DPI in a Fractured Capital Landscape](https://www.augustgp.com/opinions/underwriting-for-dpi-fractured-capital-landscape.html) — As Asia-Pacific fundraising hits a 12-year low and Southeast Asian exits fall, LPs are prioritising realised distributions. Davian Sim argues growth investors must design liquidity at entry, translate strategy into operating rigour, and anchor growth in domestic moats. - **September 2026 — AGP Perspective:** [The Asia Healthcare Growth Playbook: Why Cross-Border Structuring Matters More Than Ever](https://www.augustgp.com/opinions/asia-healthcare-growth-playbook.html) — Three structural forces — demographic weight, supply chain relocation, and capital market reordering — are reshaping Asia healthcare growth investing. The dispersion of returns will widen; cross-border structuring, regulatory literacy, and exit optionality at entry are becoming foundational rather than optional. - **May 2026 — The Business Times:** [AI Nation, Brainpower Hub: How Singapore Can Fuel Brain-Computer Interfaces Leap](https://www.businesstimes.com.sg/) — On Singapore's potential to become a global hub for brain-computer interface innovation, leveraging its strengths in AI and deep tech. - **March 2026 — The Edge Singapore:** [Southeast Asia's Healthcare Transformation: Emerging Macro Trends and AI-Driven Opportunities](https://www.theedgesingapore.com/) — Exploring how shifting demographics, rising affluence, and government initiatives are driving rapid growth in Southeast Asia's healthcare sector. - **November 2025 — DealStreetAsia:** [SE Asia Is Ripe for AI-Driven Healthcare: August Global Partners](https://www.dealstreetasia.com/) — An in-depth interview on AGP's investment thesis for AI-driven healthcare in Southeast Asia. ## Contact - **Address:** Parkview Square, 600 North Bridge Road, #10-01, Singapore 188778 - **Email:** admin@augustgp.com - **Website:** https://www.augustgp.com - **LinkedIn:** https://www.linkedin.com/company/august-global-partners/ ## About this document This document is maintained by August Global Partners as a machine-readable summary of the firm for AI agents, search crawlers, and LLM-driven research tools. For the canonical, human-facing site see https://www.augustgp.com. Structured data is available at [/data/firm.json](/data/firm.json), [/data/team.json](/data/team.json), and [/data/news.json](/data/news.json). News feed at [/feed.xml](/feed.xml). Last generated: 2026-09-10. --- ## Funds (from /funds.md) # August Global Partners — Funds > Singapore-headquartered growth-oriented fund management company investing in healthcare innovation and advanced manufacturing, with a global mandate and Asian orientation. - **AUM:** ~$350M - **Liquidity events:** 11 - **Portfolio listings:** 7 ## AGP Continuation Growth Fund (AGPCGF) - **Status:** Closed — divestment mode - **Sectors:** Healthcare services, Advanced manufacturing - **Geography:** Southeast Asia - **Stage:** Growth equity - **Highlights:** - Significant DPI achieved - 5 portfolio listings - 2 M&A exits - Actively generating distributions ## AGP Healthcare Fund (AGPHCF) - **Status:** Closed — deployment mode - **Theme:** Living Better, Aging Better - **Close size:** $150M (2025-11) - **Sectors:** Precision medicine, Diagnostics, Medical technology, Digital health, Healthcare services - **Geography:** Cross-border Asia with select global co-investments - **Stage:** Predominantly growth stage - **Highlights:** - Recognised as Tech@SG Pioneer / Recognised Investor (Feb 2026) ## Team (from /team.md) # August Global Partners — Team ## Founding Partners ### Chu Swee Yeok, PBM — Chair & Founding Partner Former CEO, President, and Executive Director of EDBI. Awarded the Pingat Bakti Masyarakat (Public Service Medal). Pioneered Singapore's first global biotech fund at EDB in the late 1980s; founding CEO of Bio*One Capital (2001). [LinkedIn](https://www.linkedin.com/in/swee-yeok-chu-pbm-16b5715/) ### Dr Basil Lui — Founding Partner and CEO Founding Partner and CEO of August Global Partners. Former EDBI colleague of Chu Swee Yeok with deep experience in healthcare, biotech, and cross-border growth investments. ## Partners ### Davian Sim — Partner Made Partner in 2026. Focus on healthcare and medtech investments. ## Venture Partners ### Shawn Tan — Venture Partner Axon Alpha Advisors; formerly Novo Tellus, EDBI. ### Ong Jeong Shing — Venture Partner Formerly EDBI, Venturecraft. ## Investments ### Dr Warren Tan — Investments ### Chris Koh — Investments [LinkedIn](https://www.linkedin.com/in/chris-koh/) ### Jay Tan — Investments AGP Investments team, focused on healthcare and biotech opportunities across Asia. Deal sourcing, due diligence, and cross-border BD support for portfolio companies. Prior: Investment Manager at AID Partners (biotech/healthcare deals across Singapore, Japan, China, Hong Kong, Israel, Indonesia); part-time biotech investment consultant to a Hong Kong venture fund; business development at Aevice Health. BSc (First Class Honours) in Biomedical Sciences and Biobusiness, Nanyang Technological University; attended the Copenhagen Business School BioEntrepreneurship program. [LinkedIn](https://www.linkedin.com/in/zhejun-jay/) ## Operations ### Jude Tan — Operations ### Jerlin Ong — Administration --- ## News (from /news.md) # August Global Partners — News > Machine-readable news feed for August Global Partners. See also [/feed.xml](/feed.xml) (RSS) and [/news.json](/news.json) (structured JSON). ## AI Benefits GPs, but Some Perks May Be Overstated - **Date:** 2026-10-07 - **Source:** DealStreetAsia - **URL:** https://www.dealstreetasia.com/stories/ai-benefits-gps-497182 - **Tags:** thought-leadership, events, artificial-intelligence, private-equity, Basil-Lui DealStreetAsia reports on "The AI test for GPs" panel at its Asia PE-VC Summit 2026, featuring Founding Partner & CEO Dr Basil Lui alongside Neuberger, TPG Asia and Collyer Capital. Dr Lui noted that AI can lower barriers to entry and pressure valuation multiples, so durable moats in manufacturing, distribution, customer relationships and proprietary networks still matter, and that investment committees must keep "the human in the loop" for final decisions. ## AGP Partner Davian Sim Speaks at SuperReturn Asia 2026 - **Date:** 2026-10-01 - **Source:** SuperReturn Asia - **URL:** https://informaconnect.com/superreturnasia/agenda/4/ - **Tags:** thought-leadership, events, private-equity, talent, Davian-Sim At SuperReturn Asia 2026 in Singapore, Partner Davian Sim joined the panel "Sourcing talent: finding the right leader for your PortCo" with Wavemaker Partners and Novo Holdings Asia on 1 October. He discussed founder-to-CEO transitions at growth stage, the leadership traits that carry across stages, and why the CFO bench matters. His perspective is in AGP's Opinions section. ## AGP Partners Speak at DealStreetAsia's Asia PE-VC Summit 2026 - **Date:** 2026-09-23 - **Source:** DealStreetAsia - **URL:** https://www.dealstreetasia.com/stories/asia-pe-vc-summit-2026-agenda-495796 - **Tags:** thought-leadership, events, private-equity, AI, Basil-Lui, Davian-Sim At DealStreetAsia's 11th Asia PE-VC Summit in Singapore, Partner Davian Sim joined the opening breakfast panel hosted by Vistra Fund Solutions, "When Global Capital Fractures: Opportunity and Friction in APAC Private Markets", on 23 September. On 24 September, Founding Partner & CEO Dr Basil Lui spoke on "The AI test for GPs: Underwriting disruption, transforming portfolios and proving value to LPs" alongside Neuberger and TPG. Both have since published their perspectives in AGP's Opinions section. ## Shape Memory Medical Secures $10M Financing Led by AGP to Advance Aortic Clinical Programs - **Date:** 2026-08-24 - **Source:** Business Wire - **URL:** https://www.businesswire.com/news/home/20260823384967/en/Shape-Memory-Medical-Secures-%2410-Million-Financing-Led-by-August-Global-Partners-to-Advance-Aortic-Clinical-Programs - **Tags:** portfolio, healthcare, medtech, financing, AGPHCF AGP leads a $10M convertible note financing in Shape Memory Medical, a California-based medical device company developing proprietary shape memory polymer technology for endovascular embolization, with participation from Taiwania Capital and support from HEAL Venture Lab. Proceeds will fund continued clinical development of the company's aortic portfolio, including patient follow-up in the AAA-SHAPE Pivotal Trial (IMPEDE-FX RapidFill®) and advancement of the FLAGSHIP first-in-human feasibility trial (False Lumen Embolization System for aortic dissection). AGP Partner Davian Sim is quoted on the platform's potential as the company reaches an inflection point across its clinical programs. ## Ambiq Micro's SGX Secondary Listing a 'Reflection of Commitment' - **Date:** 2026-07-30 - **Source:** The Business Times - **URL:** https://www.businesstimes.com.sg/companies-markets/chip-designer-ambiq-micros-secondary-listing-sgx-reflection-commitment-ceo - **Tags:** portfolio, advanced-manufacturing, edge-AI, AGPHCF AGP portfolio company Ambiq Micro announces a secondary listing on the Singapore Exchange, complementing its existing NYSE listing. CEO Fumihide Esaka describes the move as a "reflection of commitment" to Singapore and the Asia-Pacific region, alongside a multi-year R&D programme in Singapore for Ambiq's sub-threshold power optimised (Spot) platform. The article notes August Global Partners among Ambiq's investors. ## Singapore's Care Tech Race Heats Up as City-State Ages Rapidly - **Date:** 2026-07-21 - **Source:** Nikkei Asia - **URL:** https://asia.nikkei.com/spotlight/asean-money/singapore-s-care-tech-race-heats-up-as-city-state-ages-rapidly - **Tags:** thought-leadership, healthcare, eldercare, Basil-Lui Nikkei Asia features Singapore's rapidly growing eldercare technology ecosystem as the city-state becomes a super-aged society in 2026. AGP CEO Dr Basil Lui is quoted on what eldercare tech firms need to demonstrate to attract institutional private capital — "clinical and economic efficacy, with hard diagnostic data that actively reduces overall hospital readmissions or long-term care costs, along with cross-border scalability of solutions across the region." ## Gene Solutions' SPOT-MAS 10 Receives FDA Breakthrough Device Designation - **Date:** 2026-05-27 - **Source:** PR Newswire - **URL:** https://www.prnewswire.com/news-releases/fda-breakthrough-device-designation-marks-major-milestone-for-gene-solutions-spot-mas-10-multi-cancer-screening-test-302783420.html - **Tags:** portfolio, healthcare, biotech, FDA, AGPHCF AGP portfolio company Gene Solutions receives FDA Breakthrough Device Designation for SPOT-MAS 10, its 10-cancer early detection blood test based on cell-free DNA methylation analysis. ## Ambiq Accelerates Sales Growth on Edge AI Demand - **Date:** 2026-05-12 - **Source:** Investor's Business Daily - **URL:** https://www.investors.com/news/technology/ambiq-stock-ambq-accelerating-sales-growth/ - **Tags:** portfolio, advanced-manufacturing, edge-AI, AGPHCF AGP portfolio company Ambiq accelerates sales growth as edge AI demand drives adoption of its sub-threshold power optimised chips across smart devices and wearables. ## AGP Featured in DealStreetAsia's SE Asia PE Funds H2 2025 Review - **Date:** 2026-03-31 - **Source:** DealStreetAsia - **URL:** https://www.dealstreetasia.com/reports/southeast-asia-private-equity-funds-h2-2025-review - **Tags:** firm, recognition August Global Partners is featured in DealStreetAsia's semi-annual review of Southeast Asia's private equity fund landscape for H2 2025. ## AGP Recognised as Tech@SG Pioneer / Recognised Investor - **Date:** 2026-02-15 - **Source:** EDB Singapore - **URL:** https://www.edb.gov.sg/en/incentives-and-programmes/incentives-and-facilitation-programmes/tech-sg/tech-sg-recognised-investment-firms.html - **Tags:** firm, recognition, Singapore August Global Partners is recognised as a Tech@SG Pioneer / Recognised Investor by Singapore's Economic Development Board. ## UltraGreen.ai IPO - **Date:** 2025-12-02 - **Source:** Bloomberg - **URL:** https://www.bloomberg.com/news/articles/2025-12-02/ultragreen-ai-set-for-singapore-trading-debut-after-400m-ipo - **Tags:** portfolio, healthcare, medtech, IPO, AGPHCF AGP Healthcare Fund (AGPHCF) portfolio company UltraGreen.ai completes its IPO on the SGX Mainboard, the second IPO in the AGPHCF portfolio after Ambiq. ## AGPHCF Closes at $150M - **Date:** 2025-11-25 - **Source:** PR Newswire - **URL:** https://www.prnewswire.com/apac/news-releases/august-global-partners-closes-flagship-healthcare-fund-above-target-expanding-aum-to-350-million-302624245.html - **Tags:** firm, fund-close, AGPHCF The AGP Healthcare Fund (AGPHCF) formally closes at $150M, dedicated to the Living Better, Aging Better theme across precision medicine, diagnostics, medical technology, digital health, and healthcare services. ## 65 Equity Partners UltraGreen.ai - **Date:** 2025-09-15 - **Source:** The Business Times - **URL:** https://www.businesstimes.com.sg/companies-markets/ultragreen-ai-secures-us188-million-investment-round-led-65-equity-partners-and-vitruvian-partners - **Tags:** portfolio, healthcare, medtech, financing, AGPHCF 65 Equity Partners and other investors participate in UltraGreen.ai financing alongside AGP. ## Singapore's August Global Partners Invests in Gene Solutions - **Date:** 2025-01-10 - **Source:** Vietnam Investment Review - **URL:** https://vir.com.vn/singapores-august-global-partners-invests-in-gene-solutions-121104.html - **Tags:** portfolio, healthcare, genomics, AGPHCF AGP invests in Vietnam's leading genomic testing company Gene Solutions through a proprietary funding round. ## Basil Lui at PE-VC Summit - **Date:** 2024-09-15 - **Source:** DealStreetAsia - **URL:** https://events.dealstreetasia.com/sg2024/ - **Tags:** thought-leadership, Basil-Lui, firm AGP Founding Partner and CEO Dr Basil Lui speaks at DealStreetAsia's PE-VC Summit on Southeast Asia healthcare investment themes. ## Ex-EDBI Chief Launches $250M Firm - **Date:** 2023-11-02 - **Source:** e27 - **URL:** https://e27.co/edbi-ex-ceo-chu-swee-yeok-launches-us250m-fund-august-global-partners-20231102/ - **Tags:** firm, launch, AGPCGF, AGPHCF August Global Partners launches under founding partners Chu Swee Yeok PBM (former EDBI CEO) and Dr Basil Lui, with an initial platform target of ~$250M across two inaugural funds. --- ## Opinions (from /opinions.md) # August Global Partners — Opinions ## Back the Founder, Build the Bench: Leadership Lessons for Growth-Stage Investors - **Source:** AGP Perspective - **Author:** Davian Sim, CPA, Partner - **URL:** https://www.augustgp.com/opinions/backing-the-founder-building-the-bench.html At Series B and beyond, the leadership that built a company is not always the leadership that will scale it. Adapted from his SuperReturn Asia 2026 panel, Davian Sim sets out why founders must know what they don't know, the traits that travel across stages, why investors should look one level below the CEO, and how Southeast Asia's talent bench is being built. ## The AI Test for GPs: Why Judgment, Access and Hard Moats Still Decide Returns - **Source:** AGP Perspective - **Author:** Dr Basil Lui, Founding Partner and CEO - **URL:** https://www.augustgp.com/opinions/the-ai-test-for-gps.html AI is compressing the analyst layer of private markets, not the accountability layer. Adapted from his DealStreetAsia Asia PE-VC Summit 2026 panel, Dr Basil Lui explains how AGP screens for inflection points overnight, why hardware and regulatory moats matter more as software commoditises, and why investment decisions must stay human in the loop. ## From McKinsey to McDonald’s: Underwriting for DPI in a Fractured Capital Landscape - **Source:** AGP Perspective - **Author:** Davian Sim, CPA, Partner - **URL:** https://www.augustgp.com/opinions/underwriting-for-dpi-fractured-capital-landscape.html As Asia-Pacific fundraising hits a 12-year low and Southeast Asian exits fall, LPs are prioritising realised distributions. Davian Sim argues growth investors must design liquidity at entry, translate strategy into operating rigour, and anchor growth in domestic moats. ## The Asia Healthcare Growth Playbook: Why Cross-Border Structuring Matters More Than Ever - **Source:** AGP Perspective - **URL:** https://www.augustgp.com/opinions/asia-healthcare-growth-playbook.html Three structural forces — demographic weight, supply chain relocation, and capital market reordering — are reshaping Asia healthcare growth investing. The dispersion of returns will widen; cross-border structuring, regulatory literacy, and exit optionality at entry are becoming foundational rather than optional. ## AI Nation, Brainpower Hub: How Singapore Can Fuel Brain-Computer Interfaces Leap - **Source:** The Business Times - **URL:** https://www.businesstimes.com.sg/ On Singapore's potential to become a global hub for brain-computer interface innovation, leveraging its strengths in AI and deep tech. ## Southeast Asia's Healthcare Transformation: Emerging Macro Trends and AI-Driven Opportunities - **Source:** The Edge Singapore - **URL:** https://www.theedgesingapore.com/ Exploring how shifting demographics, rising affluence, and government initiatives are driving rapid growth in Southeast Asia's healthcare sector. ## SE Asia Is Ripe for AI-Driven Healthcare: August Global Partners - **Source:** DealStreetAsia - **URL:** https://www.dealstreetasia.com/ An in-depth interview on AGP's investment thesis for AI-driven healthcare in Southeast Asia. ---